<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39363197</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2318</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>BMC geriatrics</Title><ISOAbbreviation>BMC Geriatr</ISOAbbreviation></Journal><ArticleTitle>Salivary assessment of the immune/inflammatory responses and oxidative stress in older adults vaccinated with CoronaVac or ChadOx-1.</ArticleTitle><Pagination><StartPage>807</StartPage><MedlinePgn>807</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">807</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12877-024-05357-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although important information concerning COVID-19 vaccination is available, the effects of the CoronaVac and ChadOx-1 vaccines on immunity and the redox balance in the upper airway mucosa of the aged population are not fully understood. Therefore, the aim of this study was to investigate the impacts of two doses of the CoronaVac or ChadOx-1 vaccine on immune/inflammatory responses and oxidative stress in the airway mucosa of older adults.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Seventy-six older adults of both sexes, with a mean age of 75.1 ± 6.4 years, were separated according to vaccination status into the CoronaVac (n = 52) and ChadOx-1 (n = 24) groups. Saliva samples were collected before (pre) and 30 days after (post) the administration of the second dose of the CoronaVac or ChadOx-1 vaccine to assess the levels of antibodies (sIgA and IgG), antimicrobial peptides, cytokines, and oxidant/antioxidant agents.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The immunogenicity in the ChadOx-1 group was 37.5% for sIgA and 25% for IgG, while that in the CoronaVac group was 18.9% for sIgA and 13.2% for IgG. Intergroup analysis revealed that (1) lower levels of IFN-α, IFN-γ, and IL-10 and a greater IFN-γ/IL-10 ratio, in addition to a greater IL-6/IL-10 ratio, were found in both the pre- and postvaccination periods, and (2) lower levels of total sIgA, IL-12p70, IL-17A, TNF-α, and the IL-12p70/IL-10 ratio, in addition to higher levels of specific sIgA for SARS-CoV-2 antigens and lysozyme, were observed only in the postvaccination period in the ChadOx-1 group than in the CoronaVac group. Intragroup analysis revealed (1) a significant increase in the salivary levels of total peroxides in the postvaccination period compared to those in the prevaccination period in both volunteer groups; (2) a decrease in the levels of lysozyme and the ratio between total antioxidant capacity (TAC) and total peroxides in the postvaccination period in the CoronaVac group compared with those in the prevaccination period; and (3) decreases in the TNF-α, IL-6, and IL-12p70 levels, and the IL-12p70/IL-10 ratio in the ChadoX-1 group, as well as a higher lactoferrin concentration in the postvaccination period than in the prevaccination period. Several positive and negative correlations between the parameters assessed here were found.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In general, the ChadOx-1 group exhibited improvements in both immune/inflammatory responses and redox balance and greater immunogenicity than did the CoronaVac group.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Vieira</LastName><ForeName>Jeniffer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Dentistry, Campus 1, Santo Amaro University (UNISA), São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>de Oliveira</LastName><ForeName>Thiago Vinícius Vieira</ForeName><Initials>TVV</Initials><AffiliationInfo><Affiliation>Faculty of Dentistry, Campus 1, Santo Amaro University (UNISA), São Paulo, Brazil. thyaguvinny@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Queiroz</LastName><ForeName>Lorrayne Rithielle Rocha</ForeName><Initials>LRR</Initials><AffiliationInfo><Affiliation>Faculty of Dentistry, Campus 1, Santo Amaro University (UNISA), São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camargo</LastName><ForeName>Camila Tussato Soares</ForeName><Initials>CTS</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Health Sciences, Santo Amaro University (UNISA), São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nardy</LastName><ForeName>Ariane</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Health Sciences, Santo Amaro University (UNISA), São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monteiro</LastName><ForeName>Fernanda Rodrigues</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Health Sciences, Santo Amaro University (UNISA), São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>do Amaral</LastName><ForeName>Jônatas Bussador</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>ENT Research Lab, Department of Otorhinolaryngology-Head and Neck Surgery, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paixão</LastName><ForeName>Vitória</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>ENT Research Lab, Department of Otorhinolaryngology-Head and Neck Surgery, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaisberg</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ENT Research Lab, Department of Otorhinolaryngology-Head and Neck Surgery, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amirato</LastName><ForeName>Gislene Rocha</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Mane Garrincha Sport Education Center, Sports Department of the Municipality of São Paulo (SEME), São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dos Santos</LastName><ForeName>Carlos André Freitas</ForeName><Initials>CAF</Initials><AffiliationInfo><Affiliation>Discipline of Geriatrics and Gerontology, Department of Medicine, Paulista School of Medicine, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Postgraduate Program in Translational Medicine, Department of Medicine, Paulista School of Medicine, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durigon</LastName><ForeName>Edison Luiz</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Science of University of São Paulo (USP), São Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Scientific Platform Pasteur USP, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Danielle Bruna Leal</ForeName><Initials>DBL</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Science of University of São Paulo (USP), São Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Israelita Albert Einstein, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguiar</LastName><ForeName>Andressa Simões</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Science of University of São Paulo (USP), São Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infection Control Service, São Luiz Gonzaga Hospital of Santa Casa de Misericordia of São Paulo, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvares-Saraiva</LastName><ForeName>Anuska Marcelino</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Environmental and Experimental Pathology, Universidade Paulista, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heller</LastName><ForeName>Débora</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Dentistry, Cruzeiro do Sul University, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantoanelli</LastName><ForeName>Patricia Gabriela Viana</ForeName><Initials>PGV</Initials><AffiliationInfo><Affiliation>Faculty of Dentistry, Campus 1, Santo Amaro University (UNISA), São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siqueira</LastName><ForeName>Michelle Foigel</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>College of Dentistry, University of Saskatchewan, Saskatoon, SK, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva Nali</LastName><ForeName>Luiz Henrique</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Health Sciences, Santo Amaro University (UNISA), São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bachi</LastName><ForeName>André Luis Lacerda</ForeName><Initials>ALL</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Health Sciences, Santo Amaro University (UNISA), São Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2020/16371-1</GrantID><Agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</Agency><Country /></Grant><Grant><GrantID>2021/01960-4</GrantID><Agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</Agency><Country /></Grant><Grant><GrantID>2019/14115-0</GrantID><Agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Geriatr</MedlineTA><NlmUniqueID>100968548</NlmUniqueID><ISSNLinking>1471-2318</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000722216">sinovac COVID-19 vaccine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015164">Vaccines, Inactivated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="Y">Oxidative Stress</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012463" MajorTopicYN="Y">Saliva</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015164" MajorTopicYN="N">Vaccines, Inactivated</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antimicrobial peptides</Keyword><Keyword MajorTopicYN="N">Cytokines</Keyword><Keyword MajorTopicYN="N">IgG</Keyword><Keyword MajorTopicYN="N">Peroxides</Keyword><Keyword MajorTopicYN="N">Secretory immunoglobulin A</Keyword><Keyword MajorTopicYN="N">Total antioxidant capacity</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>8</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>23</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39363197</ArticleId><ArticleId IdType="pmc">PMC11448442</ArticleId><ArticleId IdType="doi">10.1186/s12877-024-05357-8</ArticleId><ArticleId IdType="pii">10.1186/s12877-024-05357-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhang J-J, Dong X, Liu G-H, Gao Y-D. Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality. Clin Rev Allergy Immunol. 2022;64:90–107. 10.1007/s12016-022-08921-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8767775</ArticleId><ArticleId IdType="pubmed">35044620</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Yuan H, Li X, Wang H. Spike protein mediated membrane fusion during SARS-CoV-2 infection. J Med Virol. 2023;95(1):e28212. 10.1002/jmv.28212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9874878</ArticleId><ArticleId IdType="pubmed">36224449</ArticleId></ArticleIdList></Reference><Reference><Citation>Dergaa I, Abubaker M, Souissi A, Mohammed AR, Varma A, Musa S, Al Naama A, Mkaouer B, Ben Saad H. Age and clinical signs as predictors of COVID-19 symptoms and cycle threshold value. Libyan J Med. 2022;17(1):2010337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8667934</ArticleId><ArticleId IdType="pubmed">34895104</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi J. A Genetic Explanation for Why Some People Had Asymptomatic COVID-19. JAMA. 2023;330(8):683–4. 10.1001/jama.2023.14703.</Citation><ArticleIdList><ArticleId IdType="pubmed">37531124</ArticleId></ArticleIdList></Reference><Reference><Citation>Varma A, Dergaa I, Mohammed AR, Abubaker M, Al Naama A, Mohammed S, Rafique MA, Manu L, Vedasalam S, Parveze P, Hammouda O, Ammar A. Covid-19 and diabetes in primary care - How do hematological parameters present in this cohort? Expert Rev Endocrinol Metab. 2021;16(3):147–53. 10.1080/17446651.2021.1909472. Epub 2021 Apr 5.</Citation><ArticleIdList><ArticleId IdType="pubmed">33818239</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexeyev MF. Is there more to aging than mitochondrial DNA and reactive oxygen species? FEBS J. 2009;276:5768–87. 10.1111/j.1742-4658.2009.07269.x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3097520</ArticleId><ArticleId IdType="pubmed">19796285</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, Liu S, Yang JK. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health. 2020;8:152. 10.3389/fpubh.2020.00152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201103</ArticleId><ArticleId IdType="pubmed">32411652</ArticleId></ArticleIdList></Reference><Reference><Citation>Dergaa I, Abubaker M, Souissi A, Mohammed AR, Varma A, Musa S, Al Naama A, Mkaouer B, Ben Saad H. Age and clinical signs as predictors of COVID-19 symptoms and cycle threshold value. Libyan J Med. 2022;17(1):2010337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8667934</ArticleId><ArticleId IdType="pubmed">34895104</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G, Dimopoulos MA. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834–47. 10.1002/ajh.25829. Epub 2020 May 23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262337</ArticleId><ArticleId IdType="pubmed">32282949</ArticleId></ArticleIdList></Reference><Reference><Citation>Löhr P, Schiele S, Arndt TT, Grützner S, Claus R, Römmele C, Müller G, Schmid C, Dennehy KM, Rank A. Impact of age and gender on lymphocyte subset counts in patients with COVID-19. Cytometry A. 2023;103(2):127–35. 10.1002/cyto.a.24470. Epub 2021 Jun 23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426831</ArticleId><ArticleId IdType="pubmed">34125495</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes AJ, Noronha A, Mafort T. Mecanismos de defesa do aparelho respiratório. Revista Hosp Universitário Pedro Ernesto. 2010;9(2).</Citation></Reference><Reference><Citation>Colbey C, Cox AJ, Pyne DB, Zhang P, Cripps AW, West NP. Upper Respiratory Symptoms, Gut Health and Mucosal Immunity in Athletes. Sports Med. 2018;48:65–77. 10.1007/s40279-017-0846-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5790851</ArticleId><ArticleId IdType="pubmed">29363055</ArticleId></ArticleIdList></Reference><Reference><Citation>Buczko P, Zalewska A, Szarmach I. Saliva and oxidative stress in oral cavity and in some systemic disorders. J Physiol Pharmacol. 2015;66(1):3–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25716960</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Schipper HM, Velly AM, Mohit S, Gornitsky M. Salivary biomarkers of oxidative stress: A critical review. Free Radic Biol Med. 2015;85:95–104. 10.1016/j.freeradbiomed.2015.04.005. Epub 2015 Apr 16.</Citation><ArticleIdList><ArticleId IdType="pubmed">25889823</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida EB, Santos JMB, Paixão V, Amaral JB, Foster R, Sperandio A, Roseira T, Rossi M, Cordeiro TG, Monteiro FR, et al. L-Glutamine Supplementation Improves the Benefits of Combined-Exercise Training on Oral Redox Balance and Inflammatory Status in Elderly Individuals. Oxidative Med Cell Longev. 2020;2020:1–13. 10.1155/2020/2852181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204202</ArticleId><ArticleId IdType="pubmed">32411324</ArticleId></ArticleIdList></Reference><Reference><Citation>Challacombe SJ, Russell MW, Hawkes J. Passage of intact IgG from plasma to the oral cavity via crevicular fluid. Clin Exp Immunol. 1978;34(3):417–22. PMID: 105828; PMCID: PMC1537551;.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1537551</ArticleId><ArticleId IdType="pubmed">105828</ArticleId></ArticleIdList></Reference><Reference><Citation>Society for Mucosal Immunology, 0. (2012). Principles of Mucosal Immunology (P. Smith, T. MacDonald, &amp; R. Blumberg, Eds.) (2nd ed.). Garland Science. 10.1201/9780429258459.</Citation></Reference><Reference><Citation>Keren G, Segev S, Morag A, Zakay-Rones Z, Barzilai A, Rubinstein E. Failure of influenza vaccination in the aged. J Med Virol. 1988;25(1):85–9. 10.1002/jmv.1890250112.</Citation><ArticleIdList><ArticleId IdType="pubmed">3411310</ArticleId></ArticleIdList></Reference><Reference><Citation>Arranz E, O'Mahony S, Barton JR, Ferguson A. Immunosenescence and mucosal immunity:significant effects of old age on secretory IgA concentrations and intraepithelial lymphocyte counts…. Gut. 1992;33(882–886). 10.1136/gut.33.7.882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1379398</ArticleId><ArticleId IdType="pubmed">1644326</ArticleId></ArticleIdList></Reference><Reference><Citation>Noda K, Kodama S, Umemoto S, Nomi N, Hirano T, Suzuki M. Th17 cells contribute to nontypeable Haemophilus influenzae-specific protective immunity induced by nasal vaccination with P6 outer membrane protein and α-galactosylceramide. Microbiol Immunol. 2011;55:574–81. 10.1111/j.1348-0421.2011.00352.x.</Citation><ArticleIdList><ArticleId IdType="pubmed">21605159</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Z, Zheng Z, Wu K, Junhua Z. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2. Aging. 2020;12:7639–51. 10.18632/aging.103101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7244084</ArticleId><ArticleId IdType="pubmed">32364527</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19. J Infect. 2020;80:607–13. 10.1016/j.jinf.2020.03.037;.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194613</ArticleId><ArticleId IdType="pubmed">32283152</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltrán-García J, Osca-Verdegal R, Pallardó FV, Ferreres J, Rodríguez M, Mulet S, Sanchis-Gomar F, Carbonell N, García-Giménez JL. Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression. Antioxidants. 2020;9:936. 10.3390/antiox9100936.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7599810</ArticleId><ArticleId IdType="pubmed">33003552</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C, Zaikin A, Gordleeva S, et al. Inflammaging 2018: An update and a model. Semin Immunol. 2018;40:1–5. 10.1016/j.smim.2018.10.008.</Citation><ArticleIdList><ArticleId IdType="pubmed">30392751</ArticleId></ArticleIdList></Reference><Reference><Citation>Galle FA, Martella D, Bresciani G. Modulación antioxidante y antiinflamatoria del ejercicio físico durante el envejecimiento. Revista Española de Geriatría y Gerontología. 2018;53(5):279–84. 10.1016/j.regg.2018.03.003.</Citation><ArticleIdList><ArticleId IdType="pubmed">29898833</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos JMB, Soares CP, Monteiro FR, Mello R, do Amaral JB, Aguiar AS, Soledade MP, Sucupira C, De Paulis M, Andrade JB, Almeida FJ, Sáfadi MAP, Mau LB, Brasil JM, Ramalho T, Loures FV, Vieira RP, Durigon EL, de Oliveira DBL, Bachi ALL. In Nasal Mucosal Secretions, Distinct IFN and IgA Responses Are Found in Severe and Mild SARS-CoV-2 Infection. Front Immunol. 2021;12:595343. 10.3389/fimmu.2021.595343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7946815</ArticleId><ArticleId IdType="pubmed">33717074</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos JMB, do Amaral JB, França CN, Monteiro FR, Alvares-Saraiva AM, Kalil S, Durigon EL, Oliveira DBL, Rodrigues SS, Heller D, Welter EAR, Pinho JRR, Vieira RP, Bachi ALL. Distinct Immunological Profiles Help in the Maintenance of Salivary Secretory IgA Production in Mild Symptoms COVID-19 Patients. Front Immunol. 2022;13:890887. 10.3389/fimmu.2022.890887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9171398</ArticleId><ArticleId IdType="pubmed">35686128</ArticleId></ArticleIdList></Reference><Reference><Citation>Paixão V, Almeida EB, Amaral JB, Roseira T, Monteiro FR, Foster R, Sperandio A, Rossi M, Amirato GR, Santos CAF, Pires RS, Leal FB, Durigon EL, Oliveira DBL, Vieira RP, Vaisberg M, Santos JMB, Bachi ALL. Elderly Subjects Supplemented with L-Glutamine Shows an Improvement of Mucosal Immunity in the Upper Airways in Response to Influenza Virus Vaccination. Vaccines (Basel). 2021;9(2):107. 10.3390/vaccines9020107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7911866</ArticleId><ArticleId IdType="pubmed">33572639</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministério da Saúde. Resolução 196. Brasília: Conselho Nacional de Saúde. 1996. [ https://bvsms.saude.gov.br/bvs/saudelegis/cns/1996/res0196_10_10_1996.html] . Accessed on 09/20/2023.</Citation></Reference><Reference><Citation>The World Medical Association. Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. Helsinki: The World Medical Association. 1964. [ https://www.wma.net/wp-content/uploads/2016/11/DoH-Oct2008.pdf] . Accessed on: 09/11/2023.</Citation></Reference><Reference><Citation>Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomized, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(2):181–92. 10.1016/S1473-3099(20)30843-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832443</ArticleId><ArticleId IdType="pubmed">33217362</ArticleId></ArticleIdList></Reference><Reference><Citation>Folegatti PM, Ewer KJ, Aley PK, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomized controlled trial. Lancet. 2020;396(10249):467–78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445431</ArticleId><ArticleId IdType="pubmed">32702298</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramasamy MN, Minassian AM, Ewer KJ, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomized, controlled, phase 2/3 trial. Lancet. 2021;396(10267):1979–93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7674972</ArticleId><ArticleId IdType="pubmed">33220855</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaisberg M, Suguri VM, Gregorio LC, Lopes JD, Bachi AL. Cytokine kinetics in nasal mucosa and sera: new insights in understanding upper-airway disease of marathon runners. Exerc Immunol Rev. 2013;19:49–59.</Citation><ArticleIdList><ArticleId IdType="pubmed">23977719</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawes C. Circadian rhythms in human salivary flow rate and composition. J Physiol. 1972;220(3):529–45. 10.1113/jphysiol.1972.sp009721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1331668</ArticleId><ArticleId IdType="pubmed">5016036</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos JGO, Migueis DP, Amaral JBD, Bachi ALL, Boggi AC, Thamboo A, Voegels RL, Pezato R. Impact of SARS-CoV-2 on saliva: TNF-⍺, IL-6, IL-10, lactoferrin, lysozyme, IgG, IgA, and IgM. J Oral Biosci. 2022;64(1):108–13. Epub 2022 Jan 25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8788095</ArticleId><ArticleId IdType="pubmed">35091065</ArticleId></ArticleIdList></Reference><Reference><Citation>Dongiovanni P, Meroni M, Casati S, Goldoni R, Thomaz DV, Kehr NS, Galimberti D, Del Fabbro M, Tartaglia GM. Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation. Int J Oral Sci. 2023;15(1):27. 10.1038/s41368-023-00231-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10310701</ArticleId><ArticleId IdType="pubmed">37386003</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins WG, Marshall SW, Batterham AM, Hanin J. Progressive statistics for studies in sports medicine and exercise science. Med Sci Sports Exerc. 2009;41(1):3–13. 10.1249/MSS.0b013e31818cb278.</Citation><ArticleIdList><ArticleId IdType="pubmed">19092709</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteban I, Bergero G, Alves C, Bronstein M, Ziegler V, Wood C, Caballero MT, Wappner D, Libster R, Perez Marc G, Polack FP. Asymptomatic COVID-19 in the elderly: dementia and viral clearance as risk factors for disease progression. Gates Open Res. 2022;5:143. 10.12688/gatesopenres.13357.2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8987012</ArticleId><ArticleId IdType="pubmed">35441127</ArticleId></ArticleIdList></Reference><Reference><Citation>Actor JK, Hwang SA, Olsen M, Zimecki M, Hunter RL Jr, Kruzel ML. Lactoferrin immunomodulation of DTH response in mice. Int Immunopharmacol. 2002;2(4):475 – 86. 10.1016/s1567-5769(01)00189-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11962727</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaisberg M, Paixão V, Almeida E, Santos J, Foster R, Rossi M, Pithon-Curi T, Gorjão R, Momesso C, Andrade M, et al. Daily Intake of Fermented Milk Containing Lactobacillus casei Shirota (Lcs) Modulates Systemic and Upper Airways Immune/Inflammatory Responses in Marathon Runners. Nutrients. 2019;11:1678. 10.3390/nu11071678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6682935</ArticleId><ArticleId IdType="pubmed">31336570</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell MW, Mestecky J. Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission. Front Immunol. 2022;13:957107. 10.3389/fimmu.2022.957107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9428579</ArticleId><ArticleId IdType="pubmed">36059541</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimecki M, Kapp J, Machnicki M, Zagulski T, Wlaszczyk A, Kübler A, Mazurier J, Spik G. Lactoferrin. Its role in maturation and function of cells of the immune system and protection against shock in mice. Adv Exp Med Biol. 1998;443:331–6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9781377</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimecki M, Mazurier J, Machnicki M, Wieczorek Z, Montreuil J, Spik G. Immunostimulatory activity of lactotransferrin and maturation of CD4- CD8- murine thymocytes. Immunol Lett. 1991;30(1):119 – 23. 10.1016/0165-2478(91)90099-v.</Citation><ArticleIdList><ArticleId IdType="pubmed">1683650</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh-Mohamed S, Isho B, Chao GYC, Zuo M, Cohen C, Lustig Y, Nahass GR, Salomon-Shulman RE, Blacker G, Fazel-Zarandi M, Rathod B, Colwill K, Jamal A, Li Z, de Launay KQ, Takaoka A, Garnham-Takaoka J, Patel A, Fahim C, Paterson A, Li AX, Haq N, Barati S, Gilbert L, Green K, Mozafarihashjin M, Samaan P, Budylowski P, Siqueira WL, Mubareka S, Ostrowski M, Rini JM, Rojas OL, Weissman IL, Tal MC, McGeer A, Regev-Yochay G, Straus S, Gingras AC, Gommerman JL. Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection. Mucosal Immunol. 2022;15(5):799–808. 10.1038/s41385-022-00511-0. Epub 2022 Apr 25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9037584</ArticleId><ArticleId IdType="pubmed">35468942</ArticleId></ArticleIdList></Reference><Reference><Citation>Childers NK, Tong G, Mitchell S, Kirk K, Russell MW, Michalek SM. A Controlled Clinical Study of the Effect of Nasal Immunization with a Streptococcus mutans Antigen Alone or Incorporated into Liposomes on Induction of Immune Responses. Infect Immun. 1999;67:618–23. 10.1128/iai.67.2.618-623.1999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC96363</ArticleId><ArticleId IdType="pubmed">9916067</ArticleId></ArticleIdList></Reference><Reference><Citation>Shillitoe EJ, Lehner T. Immunoglobulins and complement in crevicular fluid, serum and saliva in man. Arch Oral Biol. 1972;17(2):241-7. 10.1016/0003-9969(72)90206-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">4622689</ArticleId></ArticleIdList></Reference><Reference><Citation>Challacombe SJ, Russell MW, Hawkes JE, Bergmeier LA, Lehner T. Passage of immunoglobulins from plasma to the oral cavity in rhesus monkeys. Immunology. 1978;35(6):923–31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1457446</ArticleId><ArticleId IdType="pubmed">104924</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizobe-Ono L, Araújo JLP, Dos-Santos MC. Components of the innate and adaptive immunity present in human saliva. Rev Odontol UNESP. 2006;35(4):253–61.</Citation></Reference><Reference><Citation>de Freitas Santoro D, de Sousa LB, Câmara NOS, de Freitas D, de Oliveira LA. SARS-COV-2 and Ocular Surface: From Physiology to Pathology, a Route to Understand Transmission and Disease. Front Physiol. 2021;12:612319. 10.3389/fphys.2021.612319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7907452</ArticleId><ArticleId IdType="pubmed">33643063</ArticleId></ArticleIdList></Reference><Reference><Citation>Su TJ, Lu JR, Thomas RK, Cui ZF, Penfold J. The effect of Solution pH on the Structure of Lysozyme Layers Adsorbed at the Silica-Water Interface Studied by Neutron Reflection. Langmuir. 1998;14:438–45. 10.1021/la970623z.</Citation></Reference><Reference><Citation>Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93:250–6. 10.1002/jmv.26232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachi AL, Rios FJ, Vaisberg PH, Martins M, de Sá MC, Victorino AB, Foster R, Sierra AP, Kiss MA, Vaisberg M. Neuro-immuno-endocrine modulation in marathon runners. Neuroimmunomodulation. 2015;22(3):196–202. Epub 2014 Aug 27.</Citation><ArticleIdList><ArticleId IdType="pubmed">25170624</ArticleId></ArticleIdList></Reference><Reference><Citation>Brzoska J, Von Eick H, Hündgen M. Interferons in the Therapy of Severe Coronavirus Infections: A Critical Analysis and Recollection of a Forgotten Therapeutic Regimen with Interferon Beta. Drug Res. 2020;70:291–7. 10.1055/a-1170-4395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7366041</ArticleId><ArticleId IdType="pubmed">32443163</ArticleId></ArticleIdList></Reference><Reference><Citation>Kindler E, Thiel V, Weber F. Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response. Adv Virus Res. 2016;96:219–43. 10.1016/bs.aivir.2016.08.006. Epub 2016 Sep 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112302</ArticleId><ArticleId IdType="pubmed">27712625</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafarzadeh A, Nemati M, Saha B, Bansode YD, Jafarzadeh S. Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons. Viral Immunol. 2021;34(5):307–320. 10.1089/vim.2020.0076. Epub 2020 Nov 4.</Citation><ArticleIdList><ArticleId IdType="pubmed">33147113</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, Péré H, Charbit B, Bondet V, Chenevier-Gobeaux C, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369:718–24. 10.1126/science.abc6027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith P, Blumberg R, MacDonald T, Society for Mucosal, Immunology, editors. (2020). Principles of Mucosal Immunology (2nd ed.). Garland Science. 10.1201/9781317212942.</Citation></Reference><Reference><Citation>Ren W, Wang K, Yin J, Chen S, Liu G, Tan B, Wu G, Bazer FW, Peng Y, Yin Y. Glutamine-Induced Secretion of Intestinal Secretory Immunoglobulin A: A Mechanistic Perspective. Front Immunol. 2016;7:503. 10.3389/fimmu.2016.00503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5121228</ArticleId><ArticleId IdType="pubmed">27933057</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung KY, Lee SJ, Chung SM, Lee MY, Bae ON, Chung JH. Generation of free radical by interaction of iron with thiols in human plasma and its possible significance. Thromb Res. 2005;116(2):157–64. 10.1016/j.thromres.2004.11.021. Epub 2005 Jan 22.</Citation><ArticleIdList><ArticleId IdType="pubmed">15907531</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408(6809):239 – 47. 10.1038/35041687.</Citation><ArticleIdList><ArticleId IdType="pubmed">11089981</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L, Kreth J. The role of hydrogen peroxide in environmental adaptation of oral microbial communities. Oxid Med Cell Longev. 2012;2012:717843. 10.1155/2012/717843. Epub 2012 Jul 16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3405655</ArticleId><ArticleId IdType="pubmed">22848782</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrés C, De La Pérez J, Juan C, Plou F, Pérez-Lebeña E. The Role of Reactive Species on Innate Immunity. Vaccines. 2022;10:1735. 10.3390/vaccines10101735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9609844</ArticleId><ArticleId IdType="pubmed">36298601</ArticleId></ArticleIdList></Reference><Reference><Citation>Leto TL, Geiszt M. Role of Nox family NADPH oxidases in host defense. Antioxid Redox Signal. 2006;8(9–10):1549-61. 10.1089/ars.2006.8.1549.</Citation><ArticleIdList><ArticleId IdType="pubmed">16987010</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozmeric N. Advances in periodontal disease markers. Clin Chim Acta. 2004;343(1–2):1–16. 10.1016/j.cccn.2004.01.022.</Citation><ArticleIdList><ArticleId IdType="pubmed">15115674</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashby MT. Inorganic Chemistry of Defensive Peroxidases in the Human Oral Cavity. J Dent Res. 2008;87:900–14. 10.1177/154405910808701003.</Citation><ArticleIdList><ArticleId IdType="pubmed">18809743</ArticleId></ArticleIdList></Reference><Reference><Citation>Pruitt KM. The salivary peroxidase system: thermodynamic, kinetic and antibacterial properties. J Oral Pathol. 987;16(8):417–420. 10.1111/j.1600-0714.1987.tb02078.x</Citation><ArticleIdList><ArticleId IdType="pubmed">2826737</ArticleId></ArticleIdList></Reference><Reference><Citation>Diab-Ladki R, Pellat B, Chahine R. Decrease in the total antioxidant activity of saliva in patients with periodontal diseases. Clin Oral Investig. 2003;7(2):103–7. 10.1007/s00784-003-0208-5. Epub 2003 May 13.</Citation><ArticleIdList><ArticleId IdType="pubmed">12743837</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582:1783–7. 10.1016/j.febslet.2008.04.057.</Citation><ArticleIdList><ArticleId IdType="pubmed">18474236</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>